The role of type 2 diabetes in the pathogenesis of different cancers


  • Tabukashvili R.
  • Kapetivadze V.
  • Kuparadze M.
  • Lazashvili T.
  • Maglapheridze Z.


To determine the possible causal relation between T2D and cancer has been the aim of our research, to study glycemic and insulin levels in patients with tumors of different localization. Methods: 202 patients were included in the study, 118 males and 84 females. Patients were divided into two groups: The first group - 107 patients who had diabetes and one of the cancers. Individuals in the second group were diagnosed with cancer without diabetes type 2. Glycemia and insulin levels were determined in patients in both groups. The mean glycemic index in the first group was 157 mg /dL (±18); 204 mg / dl (±22) 120 minutes after feeding. Insulin levels in first group were 34.3 micU / ml (±1.2); These data did not differ significantly between tumors of different localization. The study revealed the association of diabetes mellitus with tumor pathologies of various localizations. Reliable results were obtained between respiratory tumors (OR = 5.32), digestive tumors (OR = 9.35), female genital tumors (OR = 5.34), and the presence of diabetes. As for the association of urinary tract tumors with diabetes, the obtained results were not statistically reliable. There is a statistically reliable link between respiratory system, digestive system and female genital cancers and diabetes.


Download data is not yet available.

References boti-14-milioni-kaci-avaddeba-da-8-200-000-kvdeba-

GDM. A Statistical Study in Cancer Death Rates. Biometrika. 1910; 7:276304.

Bowker S.L., Majumdar S.R., Veugelers P., Johnson J.A. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin// Diabetes Care. 2006. N 29(2). -P 254258.

Vigneri P., Frasca F., Sciacca L., Pandini G., Vignery R. Diabetes and cancer // Endocrine-Related Cancer. -2009. N 16 (4). -P. 1103-1123. Cancer Causes Control 2012;23: 967-981

El-Serag H.B., Hampel H., Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence // Clinical Gastroenterology and Hepatology. 2006. N 4. P. 369680.

Kundu JK, Surh YJ. Inflammation: gearing the journey tocancer. Mutat Res 2008; 659: 15-30 [PMID: 18485806 DOI: 12.1016/j. mrrev.2008.03.002]

Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, Zuppi C, Ghirlanda G. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud 2010; 7: 15-25 [PMID: 20703435 DOI: 10.1900/RDS.2010.7.15]

DiDonato JA, Mercurio F, Karin M. NF-êB and the link between inflammation and cancer. Immunol Rev 2012; 246: 379-400 [PMID: 22435567 DOI: 10.1111/j.1600-065X.2012. 01099. x]

Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer 2009; 16: 1103-1123 [PMID:

Ruying Hu 1, Jin Pan 1, Feng Lu 1, Qingfang He 1, Naxin Cao 2, Yong Wang 2, Zhen Ye 1, Min Yu 3, Guang Ning 4 Study on the relationship between level of glucose metabolism and risk of cancer incidents][Article in Chinese]

Edward Giovannucci, David M. Harlan, Michael Pollak, Judith G. Regensteiner, Douglas Yee Diabetes and Cancer. A consensus report.

J Res Med Sci. 2019; 24: 94. Published online 2019 Oct 25.doi: 10.4103/jrms.JRMS_242_19PMCID: PMC6856544 PMID : 31741666 Diabetes and cancer: A comprehensive review Manal Abudawood.



How to Cite

Tabukashvili R., Kapetivadze V., Kuparadze M., Lazashvili T., & Maglapheridze Z. (2021). The role of type 2 diabetes in the pathogenesis of different cancers. TSMU COLLECTION OF SCIENTIFIC WORKS, 54. Retrieved from